{"id":58971,"date":"2024-03-01T13:04:02","date_gmt":"2024-03-01T12:04:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/"},"modified":"2024-03-01T13:04:02","modified_gmt":"2024-03-01T12:04:02","slug":"2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/","title":{"rendered":"2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div>\n<p>CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/TSVT?src=hash\" target=\"_blank\" rel=\"noopener\">#TSVT<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.2seventybio.com%2F&amp;esheet=53903734&amp;newsitemid=20240301891782&amp;lan=en-US&amp;anchor=2seventy+bio%2C+Inc&amp;index=1&amp;md5=4bc1a80d1c121ec2b582c45e51e4fe06\" rel=\"nofollow noopener\" shape=\"rect\">2seventy bio, Inc<\/a>. (Nasdaq: TSVT) will announce its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024. A conference call and webcast will be held at 8:00 a.m. ET.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240301891782\/en\/1257457\/5\/2seventy_logo_for_BW.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240301891782\/en\/1257457\/21\/2seventy_logo_for_BW.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240301891782\/en\/1257457\/5\/2seventy_logo_for_BW.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240301891782\/en\/1257457\/22\/2seventy_logo_for_BW.jpg\"><\/a><\/p>\n<p>\nMembers of the management team will also be presenting at the following upcoming investor conferences:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nTD Cowen 44<sup>th<\/sup> Annual Healthcare Conference in Boston, MA on Wednesday, March 6, 2024 at 2:10 p.m. ET<\/li>\n<li>\nLeerink Partners Global Biopharma Conference in Miami, FL on Wednesday, March 13 at 8:00 a.m. ET<\/li>\n<\/ul>\n<p>\nLive webcasts of the investor conference presentations will be available via the Investors and Media section of 2seventy bio\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.2seventybio.com%2F&amp;esheet=53903734&amp;newsitemid=20240301891782&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.2seventybio.com%2F&amp;index=2&amp;md5=dc20c7af663178c8e86e5f9cbb44e03b\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/ir.2seventybio.com\/<\/a>. Replays will be archived on 2seventy bio\u2019s site for 30 days following the event.<\/p>\n<p>\n<b>Earnings Call Information<\/b><\/p>\n<p>\n2seventy bio will host a conference call and live webcast on March 5, at 8:00 a.m. ET to discuss fourth quarter 2023 \/ full year 2023 financial results and recent business highlights. To join the live conference call, please register at: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fregister.vevent.com%2Fregister%2FBI1f96356c45184868a0cde91b2864ffd8&amp;esheet=53903734&amp;newsitemid=20240301891782&amp;lan=en-US&amp;anchor=https%3A%2F%2Fregister.vevent.com%2Fregister%2FBI1f96356c45184868a0cde91b2864ffd8&amp;index=3&amp;md5=02140f0690dbf68e65ca64020fc19ca4\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/register.vevent.com\/register\/BI1f96356c45184868a0cde91b2864ffd8<\/a>. Upon registering, each participant will be provided with call details and access codes. The live webcast may be accessed by visiting the event link at: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2F3ob85kez%2F&amp;esheet=53903734&amp;newsitemid=20240301891782&amp;lan=en-US&amp;anchor=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2F3ob85kez%2F&amp;index=4&amp;md5=a3275c5af169c42f0de5b210754d12b0\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/edge.media-server.com\/mmc\/p\/3ob85kez\/<\/a>.<\/p>\n<p>\nA replay of the webcast may be accessed from the \u201cNews and Events\u201d page in the Investors and Media section of the Company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.2seventybio.com%2F&amp;esheet=53903734&amp;newsitemid=20240301891782&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.2seventybio.com%2F&amp;index=5&amp;md5=8a0c923a4dc84e742ddc9d8071978357\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/ir.2seventybio.com\/<\/a> and will be available for 30 days following the event.<\/p>\n<p>\n<b><span class=\"bwuline\">About 2seventy bio<\/span><\/b><\/p>\n<p>\nOur name, 2seventy bio, reflects why we do what we do &#8211; TIME. Cancer rips time away, and our goal is to work at the maximum speed of translating human thought into action \u2013 270 miles per hour \u2013 to give the people we serve more time. With a deep understanding of the human body\u2019s immune response to tumor cells and how to translate cell therapies into practice, we\u2019re applying this knowledge to deliver the first FDA-approved CAR T cell therapy for multiple myeloma. We are focused on delivering therapies that are designed with the goal to \u201cthink\u201d smarter and faster than the disease. Importantly, we remain focused on accomplishing these goals by staying genuine and authentic to our \u201cwhy\u201d and keeping our people and culture top of mind every day.<\/p>\n<p>\nFor more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.2seventybio.com%2F&amp;esheet=53903734&amp;newsitemid=20240301891782&amp;lan=en-US&amp;anchor=www.2seventybio.com.&amp;index=6&amp;md5=e43513f2490c3f6f00731dc0c2cb69f0\" rel=\"nofollow noopener\" shape=\"rect\">www.2seventybio.com.<\/a><\/p>\n<p>\nFollow 2seventy bio on social media: <a target=\"_blank\" href=\"https:\/\/twitter.com\/2seventybio\" id=\"smartlink6\" rel=\"nofollow noopener\" shape=\"rect\">X<\/a> (formerly Twitter) and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F2seventybio%2F&amp;esheet=53903734&amp;newsitemid=20240301891782&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=7&amp;md5=9359ea1f59f6479cc6ccf6f09f6ebeae\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>.<\/p>\n<p>\n2seventy bio is a trademark of 2seventy bio, Inc.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investors:<\/b><br \/>Elizabeth Pingpank Hickin, 860-463-0469<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;:E&#108;&#105;&#x7a;&#x61;&#x62;e&#116;&#104;&#46;&#x70;&#x69;&#x6e;g&#112;&#97;&#x6e;&#x6b;&#x40;2s&#101;&#118;&#x65;&#x6e;&#x74;y&#98;&#105;&#111;&#x2e;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x45;&#x6c;&#105;z&#x61;&#x62;&#101;&#116;h&#x2e;&#x70;&#105;&#110;g&#x70;&#x61;&#110;k&#64;&#x32;&#x73;&#101;v&#x65;&#x6e;&#116;&#121;b&#x69;&#x6f;&#46;&#99;o&#x6d;<\/a><\/p>\n<p><b>Media<\/b>:<br \/>\n<br \/>Jenn Snyder, 617-448-0281<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;:&#x4a;e&#x6e;n&#46;&#x73;&#110;&#x79;&#100;&#x65;&#114;&#x40;2&#x73;e&#x76;e&#110;&#x74;&#121;&#x62;&#105;&#x6f;&#46;&#x63;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">J&#101;&#110;&#x6e;&#x2e;&#x73;ny&#100;&#101;&#x72;&#x40;&#x32;s&#101;&#118;&#101;&#x6e;&#x74;&#x79;b&#105;&#111;&#x2e;&#x63;&#x6f;m<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;#TSVT&#8212;2seventy bio, Inc. (Nasdaq: TSVT) will announce its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Members of the management team will also be presenting at the following upcoming investor conferences: TD Cowen 44th Annual Healthcare &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58971","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;#TSVT&#8212;2seventy bio, Inc. (Nasdaq: TSVT) will announce its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Members of the management team will also be presenting at the following upcoming investor conferences: TD Cowen 44th Annual Healthcare ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-01T12:04:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240301891782\/en\/1257457\/21\/2seventy_logo_for_BW.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences\",\"datePublished\":\"2024-03-01T12:04:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":444,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240301891782\\\/en\\\/1257457\\\/21\\\/2seventy_logo_for_BW.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240301891782\\\/en\\\/1257457\\\/21\\\/2seventy_logo_for_BW.jpg\",\"datePublished\":\"2024-03-01T12:04:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240301891782\\\/en\\\/1257457\\\/21\\\/2seventy_logo_for_BW.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240301891782\\\/en\\\/1257457\\\/21\\\/2seventy_logo_for_BW.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences - Pharma Trend","og_description":"CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;#TSVT&#8212;2seventy bio, Inc. (Nasdaq: TSVT) will announce its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Members of the management team will also be presenting at the following upcoming investor conferences: TD Cowen 44th Annual Healthcare ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2024-03-01T12:04:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240301891782\/en\/1257457\/21\/2seventy_logo_for_BW.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences","datePublished":"2024-03-01T12:04:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/"},"wordCount":444,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240301891782\/en\/1257457\/21\/2seventy_logo_for_BW.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/","url":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/","name":"2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240301891782\/en\/1257457\/21\/2seventy_logo_for_BW.jpg","datePublished":"2024-03-01T12:04:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240301891782\/en\/1257457\/21\/2seventy_logo_for_BW.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240301891782\/en\/1257457\/21\/2seventy_logo_for_BW.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-fourth-quarter-and-full-year-2023-financial-results-and-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58971"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58971\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58971"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58971"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}